United Therapeutics
UTHR
$272.22
Share price
-0.17%
Change (1 day)
28.38%
Change (1 year)
Categories
United Therapeutics (UTHR) Fails to deliver data
Key failure to deliver metrics for United Therapeutics:
- Last SEC data release: 2024-04-30
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: $0.33 M
- Last year FTD volume: $57.59 M
Failures to deliver for United Therapeutics (UTHR) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for United Therapeutics (UTHR) - since 2013
Volume in USD (price x number of shares), data since 2013United Therapeutics (UTHR) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.38 M | -99.34% |
| 2023 | $57.77 M | -26.42% |
| 2022 | $78.52 M | 115.57% |
| 2021 | $36.42 M | 104.98% |
| 2020 | $17.77 M | -17.63% |
| 2019 | $21.57 M | 59.84% |
| 2018 | $13.49 M | -48.63% |
| 2017 | $26.27 M | -36.88% |
| 2016 | $41.62 M | -20.33% |
| 2015 | $52.24 M | -40.31% |
| 2014 | $87.52 M | 313.6% |
| 2013 | $21.16 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Pfizer PFE | $10.32 M | $0.31 B | 🇺🇸 USA |
 Eli Lilly LLY | $56.64 M | $0.12 B | 🇺🇸 USA |
 Baxter BAX | $10.57 M | $49.06 M | 🇺🇸 USA |
 Gilead Sciences GILD | $3.99 M | $0.25 B | 🇺🇸 USA |
 Cardinal Health CAH | $52.25 M | $95.09 M | 🇺🇸 USA |
 GlaxoSmithKline GSK | $18.31 M | $24.09 M | 🇬🇧 UK |
 Cytokinetics
CYTK | $37.8 M | $98.88 M | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $5.61 M | $30.31 M | 🇮🇱 Israel |